At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
estrogen +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coronary Drug Project Mortality Surveillance
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 26, 2013
In Brief
A clinical study evaluating estrogen, clofibrate, and 2 other interventions for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
19811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1981
Study CompletionMar 1985
First PostedOct 1999
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartJun 1, 1981
Study CompletionMar 1, 1985
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
estrogendrug
clofibratedrug
dextrothyroxine sodiumdrug
niacindrug